The present proposal stems from our recent observations that orotic acid, a precursor of pyrimidine nucleotides is not only an excellent liver tumor promoter but also has the potential to be a multiorgan tumor promoter. Unlike most of the tumor promoters, orotic acid does not induce cell proliferation either in the liver or in the colon, the 2 organs examined. A new hypothesis was postulated i.e. an imbalance in nucleotide pools such as the one that occurs following orotic acid feeding appears to play an important role in the promotion phase of the carcinogenic process. In the present proposal experiments are designed to characterize the Orotic Acid Model of liver tumor promotion in greater detail. In order to study the mechanism of tumor promotion, in the present proposal experiments are designed to obtain far fewer nodules but with increased probability of progressing to cancer. For example rats will be initiated with diethylnitrosamine and will be exposed to 1% orotic acid 5 or 10 weeks after initiation rather than 1 week after initiation. In a preliminary experiments such a protocol resulted in 1 or 2 nodules per rat with 100% incidence of nodules at the end of 20-40 weeks, and with 1 hepatocellular carcinoma. To test the multiorgan tumor potential of orotic acid, the effect of orotic acid on the intestinal carcinogenesis initiated with azoxymethane and on the urinary bladder carcinogenesis initiated with N-butyl-N-(4-hydroxybutyl) nitrosamine will be tested. Preliminary results indicated that orotic acid does indeed promote intestinal carcinogenesis initiated with azoxymethane. Some attractive features of this model that have human relevance are, orotic acid is a normal cellular constituent and present in the cow's milk in considerable quantities. Increased orotic acid in milk, serum and urine occurs in some hereditary disorders and such and increase can also be achieved by metabolic disturbances and dietary means such as high protein or amino acids intake. Unfortunately, disturbances of this kind and high protein intake are not uncommon in human population at large.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA037077-06
Application #
3174752
Study Section
Chemical Pathology Study Section (CPA)
Project Start
1984-04-01
Project End
1990-03-31
Budget Start
1989-04-01
Budget End
1990-03-31
Support Year
6
Fiscal Year
1989
Total Cost
Indirect Cost
Name
University of Toronto
Department
Type
DUNS #
259999779
City
Toronto
State
ON
Country
Canada
Zip Code
M5 1S8
Laconi, S; Curreli, F; Diana, S et al. (1999) Liver regeneration in response to partial hepatectomy in rats treated with retrorsine: a kinetic study. J Hepatol 31:1069-74
Manjeshwar, S; Rao, P M; Rajalakshmi, S et al. (1999) The regulation of ribonucleoside diphosphate reductase by the tumor promoter orotic acid in normal rat liver in vivo. Mol Carcinog 24:188-96
Tomasi, C; Laconi, E; Laconi, S et al. (1999) Effect of fasting/refeeding on the incidence of chemically induced hepatocellular carcinoma in the rat. Carcinogenesis 20:1979-83
Yusuf, A; Rao, P M; Rajalakshmi, S et al. (1999) Development of resistance during the early stages of experimental liver carcinogenesis. Carcinogenesis 20:1641-4
Yusuf, A; Laconi, E; Rao, P M et al. (1999) The effect of 1/3 partial hepatectomy on the growth of glutathione S-transferase positive foci. Carcinogenesis 20:1143-5
Vasudevan, S; Laconi, E; Rao, P M et al. (1998) Cycloheximide sensitivity of orotic acid biosynthesis induced by ammonia and glycine administration. Eur J Biochem 251:597-604
Laconi, E; Yusuf, A; Jahangir, A R et al. (1997) Transient inhibition by orotic acid does not abolish the in vivo response of rat hepatocytes to a direct mitogen, lead nitrate. J Hepatol 26:203-8
Laconi, E; Sarma, D S; Pani, P (1995) Transplantation of normal hepatocytes modulates the development of chronic liver lesions induced by a pyrrolizidine alkaloid, lasiocarpine. Carcinogenesis 16:139-42
Laconi, E; Tessitore, L; Milia, G et al. (1995) The enhancing effect of fasting/refeeding on the growth of nodules selectable by the resistant hepatocyte model in rat liver. Carcinogenesis 16:1865-9
Pascale, R M; Simile, M M; De Miglio, M R et al. (1995) Chemoprevention by S-adenosyl-L-methionine of rat liver carcinogenesis initiated by 1,2-dimethylhydrazine and promoted by orotic acid. Carcinogenesis 16:427-30

Showing the most recent 10 out of 48 publications